After administering BA, the expressions of NF-κB, TLR2, and MYD88 in the COPD + MB group and COPD + HB group were significantly lower than those in the COPD group (P < 0.05 or P < 0.01). Here, NFKB1 is linked to chronic obstructive pulmonary disease.